The National Institute of Mental Health (NIMH) has announced a new funding opportunity to support clinical research aimed at developing evidence-based treatment approaches for adult Attention-Deficit Hyperactivity Disorder (ADHD) that go beyond stimulant medications. While stimulants remain a primary therapy for ADHD, many adults experience limited effectiveness, poor tolerability, or concerns related to dependence. This
Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members: